These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 995439)

  • 1. Conditioning in human opiate addicts.
    O'Brien CP; Testa T; O'Brien TJ; Greenstein R
    Pavlov J Biol Sci; 1976; 11(4):195-202. PubMed ID: 995439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioning of narcotic abstinence symptoms in human subjects.
    O'Brien CP; O'Brien TJ; Mintz J; Brady JP
    Drug Alcohol Depend; 1975 Dec; 1(2):115-23. PubMed ID: 1235105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioned narcotic withdrawal in humans.
    O'Brien CP; Testa T; O'Brien TJ; Brady JP; Wells B
    Science; 1977 Mar; 195(4282):1000-2. PubMed ID: 841320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute physical dependence in man: effects of naloxone after brief morphine exposure.
    Bickel WK; Stitzer ML; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):126-32. PubMed ID: 3335995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.
    Rosado J; Walsh SL; Bigelow GE; Strain EC
    Drug Alcohol Depend; 2007 Oct; 90(2-3):261-9. PubMed ID: 17517480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extinguishing conditioned responses during opiate dependence treatment turning laboratory findings into clinical procedures.
    McLellan AT; Childress AR; Ehrman R; O'Brien CP; Pashko S
    J Subst Abuse Treat; 1986; 3(1):33-40. PubMed ID: 2874232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular absorption of naloxone in narcotic addicts.
    Duncalf D; Jeyaram C; Tarter R; Foldes FF
    Int J Addict; 1975; 10(1):23-7. PubMed ID: 1126766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of sequential naloxone challenge tests.
    Rosen MI; McMahon TJ; Margolin A; Gill TS; Woods SW; Pearsall HR; Kreek MJ; Kosten TR
    Am J Drug Alcohol Abuse; 1995 Nov; 21(4):453-67. PubMed ID: 8561097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
    Kanof PD; Handelsman L; Aronson MJ; Ness R; Cochrane KJ; Rubinstein KJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):355-63. PubMed ID: 1731046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].
    Ge Y; Li M; Sun WL; Cai ZJ
    Yao Xue Xue Bao; 1994; 29(4):256-60. PubMed ID: 7976340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioned withdrawal drives heroin consumption and decreases reward sensitivity.
    Kenny PJ; Chen SA; Kitamura O; Markou A; Koob GF
    J Neurosci; 2006 May; 26(22):5894-900. PubMed ID: 16738231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate withdrawal.
    Farrell M
    Addiction; 1994 Nov; 89(11):1471-5. PubMed ID: 7841858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditioned behavioral and physiological changes associated with injections of a narcotic antagonist in morphine-dependent monkeys.
    Goldberg SR
    Pavlov J Biol Sci; 1976; 11(4):203-21. PubMed ID: 825815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat.
    Shippenberg TS; Funada M; Schutz CG
    Psychopharmacology (Berl); 2000 Sep; 151(4):351-8. PubMed ID: 11026742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opiate withdrawal in anesthesia (forced narcotic withdrawal, "turbo withdrawal") in narcotic dependence. Changes in withdrawal treatment--wishes and reality].
    Dettling M; Tretter F
    Nervenarzt; 1996 Sep; 67(9):805-10. PubMed ID: 8992381
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose dependent effects of yohimbine on methadone maintained patients.
    Hameedi FA; Woods SW; Rosen MI; Pearsall HR; Kosten TR
    Am J Drug Alcohol Abuse; 1997 May; 23(2):327-33. PubMed ID: 9143642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.